LCTX
Lineage Cell Therapeutics, Inc. · Healthcare
Broadwood Partners, L.P. bought $7.0M of Lineage Cell Therapeutics, Inc.
Director and 10% owner
Bought$7,000,001
$1.04Price
6,730,770Shares
+9%Stake
What LCTX did for a copier
- $1,000 copied at Fri, Feb 9 open, $1.14
- $1,123
- S&P 500, same days
- +4.5%
Measured over 30 trading days, to the Mar 25 close.
Broadwood Partners, L.P.'s record
28 other buys with 3 months of prices since 2018: on average −1.5% against the S&P 500, and 12 of 28 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Feb 6. Filed Thu, Feb 8, 6:58 PM ET, after the close. Returns use the Feb 9 open and the Mar 25 close. Not investment advice.